EP1087766A4 - TREATMENT METHOD - Google Patents
TREATMENT METHODInfo
- Publication number
- EP1087766A4 EP1087766A4 EP99930327A EP99930327A EP1087766A4 EP 1087766 A4 EP1087766 A4 EP 1087766A4 EP 99930327 A EP99930327 A EP 99930327A EP 99930327 A EP99930327 A EP 99930327A EP 1087766 A4 EP1087766 A4 EP 1087766A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Addiction (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9812941 | 1998-06-16 | ||
GBGB9812941.4A GB9812941D0 (en) | 1998-06-16 | 1998-06-16 | Method of treatment |
PCT/US1999/013623 WO1999065491A1 (en) | 1998-06-16 | 1999-06-16 | Method of treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1087766A1 EP1087766A1 (en) | 2001-04-04 |
EP1087766A4 true EP1087766A4 (en) | 2001-11-21 |
Family
ID=10833832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99930327A Withdrawn EP1087766A4 (en) | 1998-06-16 | 1999-06-16 | TREATMENT METHOD |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1087766A4 (pt) |
JP (1) | JP2002518330A (pt) |
KR (1) | KR20010052895A (pt) |
CN (1) | CN1305379A (pt) |
AP (1) | AP2000002002A0 (pt) |
AU (1) | AU740749B2 (pt) |
BG (1) | BG105127A (pt) |
BR (1) | BR9911150A (pt) |
CA (1) | CA2335236A1 (pt) |
CZ (1) | CZ20004698A3 (pt) |
EA (1) | EA003584B1 (pt) |
GB (1) | GB9812941D0 (pt) |
HU (1) | HUP0102507A3 (pt) |
IL (1) | IL139943A0 (pt) |
NO (1) | NO20006383L (pt) |
NZ (1) | NZ508532A (pt) |
PL (1) | PL345261A1 (pt) |
SK (1) | SK19192000A3 (pt) |
WO (1) | WO1999065491A1 (pt) |
ZA (1) | ZA200007396B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001296084A1 (en) * | 2000-08-28 | 2002-03-13 | Synthon B.V. | Paroxetine compositions and processes for making the same |
IL162666A0 (en) | 2001-12-28 | 2005-11-20 | Teva Pharma | A stable pharmaceutical formulation of paroxetine hydrochloride and a process for preparation thereof |
US20060039975A1 (en) * | 2004-08-20 | 2006-02-23 | Zalman Vilkov | Paroxetine formulations |
FR2926221A1 (fr) * | 2008-01-14 | 2009-07-17 | Tassin Thomas | Compositions permettant la reproduction artificielle des conditions pharmacologiques de la dependance aux drogues addictives telles que opiaces, psychostimulants, tabac et alcool, par la combinaison de nicotine et d'un ligand. |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996024595A1 (en) * | 1995-02-06 | 1996-08-15 | Smithkline Beecham Plc | New forms of paroxetin hydrochloride |
WO1997034602A1 (en) * | 1996-03-20 | 1997-09-25 | Smithkline Beecham Plc | Paroxetine in treatment of depression |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0223403B1 (en) * | 1985-10-25 | 1993-08-04 | Beecham Group Plc | Piperidine derivative, its preparation, and its use as medicament |
CA2096853A1 (en) * | 1990-11-24 | 1992-05-25 | Anthony Michael Johnson | Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
-
1998
- 1998-06-16 GB GBGB9812941.4A patent/GB9812941D0/en not_active Ceased
-
1999
- 1999-06-16 AU AU46885/99A patent/AU740749B2/en not_active Ceased
- 1999-06-16 SK SK1919-2000A patent/SK19192000A3/sk unknown
- 1999-06-16 WO PCT/US1999/013623 patent/WO1999065491A1/en not_active Application Discontinuation
- 1999-06-16 CN CN99807465A patent/CN1305379A/zh active Pending
- 1999-06-16 CZ CZ20004698A patent/CZ20004698A3/cs unknown
- 1999-06-16 NZ NZ508532A patent/NZ508532A/en unknown
- 1999-06-16 CA CA002335236A patent/CA2335236A1/en not_active Abandoned
- 1999-06-16 KR KR1020007014240A patent/KR20010052895A/ko not_active Application Discontinuation
- 1999-06-16 PL PL99345261A patent/PL345261A1/xx not_active Application Discontinuation
- 1999-06-16 JP JP2000554371A patent/JP2002518330A/ja not_active Withdrawn
- 1999-06-16 AP APAP/P/2000/002002A patent/AP2000002002A0/en unknown
- 1999-06-16 EP EP99930327A patent/EP1087766A4/en not_active Withdrawn
- 1999-06-16 EA EA200100041A patent/EA003584B1/ru not_active IP Right Cessation
- 1999-06-16 HU HU0102507A patent/HUP0102507A3/hu unknown
- 1999-06-16 BR BR9911150-0A patent/BR9911150A/pt not_active Application Discontinuation
- 1999-06-16 IL IL13994399A patent/IL139943A0/xx unknown
-
2000
- 2000-12-12 ZA ZA200007396A patent/ZA200007396B/xx unknown
- 2000-12-14 NO NO20006383A patent/NO20006383L/no unknown
-
2001
- 2001-01-08 BG BG105127A patent/BG105127A/xx unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996024595A1 (en) * | 1995-02-06 | 1996-08-15 | Smithkline Beecham Plc | New forms of paroxetin hydrochloride |
WO1997034602A1 (en) * | 1996-03-20 | 1997-09-25 | Smithkline Beecham Plc | Paroxetine in treatment of depression |
Non-Patent Citations (3)
Title |
---|
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; LEVIN EDWARD D_(A): "Sertraline attenuates hyperphagia in rats following nicotine withdrawal.", XP002173579, retrieved from DIALOG * |
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1993, vol. 44, pages 51 - 61 * |
See also references of WO9965491A1 * |
Also Published As
Publication number | Publication date |
---|---|
WO1999065491A1 (en) | 1999-12-23 |
EA200100041A1 (ru) | 2001-06-25 |
NO20006383D0 (no) | 2000-12-14 |
AP2000002002A0 (en) | 2000-12-31 |
ZA200007396B (en) | 2002-02-27 |
IL139943A0 (en) | 2002-02-10 |
GB9812941D0 (en) | 1998-08-12 |
EA003584B1 (ru) | 2003-06-26 |
JP2002518330A (ja) | 2002-06-25 |
KR20010052895A (ko) | 2001-06-25 |
HUP0102507A2 (hu) | 2002-05-29 |
CZ20004698A3 (cs) | 2002-02-13 |
AU4688599A (en) | 2000-01-05 |
EP1087766A1 (en) | 2001-04-04 |
PL345261A1 (en) | 2001-12-03 |
HUP0102507A3 (en) | 2003-12-29 |
NZ508532A (en) | 2003-08-29 |
NO20006383L (no) | 2000-12-14 |
CA2335236A1 (en) | 1999-12-23 |
CN1305379A (zh) | 2001-07-25 |
BR9911150A (pt) | 2001-03-06 |
BG105127A (en) | 2001-11-30 |
AU740749B2 (en) | 2001-11-15 |
SK19192000A3 (sk) | 2001-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9824436D0 (en) | Methods of treatment | |
HU0001471D0 (en) | New method of treatment | |
GB9715295D0 (en) | Novel method of treatment | |
GB9712866D0 (en) | Novel method of treatment | |
GB9707693D0 (en) | Novel method of treatment | |
GB9715298D0 (en) | Novel method of treatment | |
PL341667A1 (en) | Method of treating cooped | |
GB9715306D0 (en) | Novel method of treatment | |
PL345261A1 (en) | Method of treatment | |
PL349421A1 (en) | Novel method of treatment | |
GB9822681D0 (en) | Method of treatment | |
GB9822459D0 (en) | Method of treatment | |
GB9818776D0 (en) | Method of treatment | |
GB9811961D0 (en) | Method of treatment | |
GB9808479D0 (en) | Method of treatment | |
EG24158A (en) | Novel method of treatment | |
GB9824871D0 (en) | Novel method of treatment | |
GB9824790D0 (en) | Novel method of treatment | |
GB9824789D0 (en) | Novel method of treatment | |
SI1135128T1 (sl) | Nov postopek zdravljenja | |
GB9822458D0 (en) | Methods of treatment | |
GB9800707D0 (en) | Methods of treatment | |
GB9824208D0 (en) | Methods of treatment | |
GB9717399D0 (en) | Method of treatment | |
GB9724289D0 (en) | Method of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001128 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: RO PAYMENT 20001128;SI PAYMENT 20001128 |
|
RIC1 | Information provided on ipc code assigned before grant |
Free format text: 7A 61K 31/445 A, 7A 61K 9/20 B |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20011008 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20040217 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040629 |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1035669 Country of ref document: HK |